Accessibility Menu
 
Inventiva logo

Inventiva

(NASDAQ) IVA

Current Price$5.16
Market Cap$1.07B
Since IPO (2020)-62%
5 Year-60%
1 Year+37%
1 Month-14%

Inventiva Financials at a Glance

Market Cap

$1.07B

Revenue (TTM)

$13.68M

Net Income (TTM)

$537.03M

EPS (TTM)

$-2.84

P/E Ratio

-1.81

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Price

$5.16

Volume

7,779

Open

$5.17

Previous Close

$5.16

Daily Range

$5.13 - $5.23

52-Week Range

$2.85 - $7.98

IVA News

No articles available.

IVA: Motley Fool Moneyball Superscore

40

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Inventiva

Industry

Biotechnology

Employees

77

CEO

Andrew Obenshain, MBA

Headquarters

Daix, 21121, FR

IVA Financials

Key Financial Metrics (TTM)

Gross Margin

35%

Operating Margin

-30%

Net Income Margin

-79%

Return on Equity

0%

Return on Capital

-79%

Return on Assets

-1%

Earnings Yield

-55.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.07B

Shares Outstanding

207.62M

Volume

7.78K

Short Interest

0.00%

Avg. Volume

396.97K

Financials (TTM)

Gross Profit

$1.51M

Operating Income

$130.95M

EBITDA

$128.15M

Operating Cash Flow

$100.98M

Capital Expenditure

$237.25K

Free Cash Flow

$101.22M

Cash & ST Invst.

$99.27M

Total Debt

$59.40M

Inventiva Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$28.79K

-99.8%

Gross Profit

$1.17M

-107.3%

Gross Margin

-40.62%

N/A

Market Cap

$1.07B

N/A

Market Cap/Employee

$9.38M

N/A

Employees

114

N/A

Net Income

$176.94M

-220.8%

EBITDA

$77.74M

-62.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$39.87M

+492.9%

Accounts Receivable

$9.12M

-42.0%

Inventory

$0.00

-100.0%

Long Term Debt

$27.54M

-14.4%

Short Term Debt

$31.86M

+500.2%

Return on Assets

-1.42%

N/A

Return on Invested Capital

-79.10%

N/A

Free Cash Flow

$54.45M

-48.4%

Operating Cash Flow

$54.26M

-49.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GNFTGenfit S.A.
$8.95+4.07%
NAUTNautilus Biotechnology, Inc.
$2.62+1.55%
ENTAEnanta Pharmaceuticals, Inc.
$13.31-0.30%
OBIOOrchestra BioMed Holdings, Inc.
$4.13-0.48%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.17+0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.23-0.09%
TQQQProShares Trust - ProShares UltraPro Qqq
$62.56+0.06%
POETPoet Technologies
$15.10+0.29%

Questions About IVA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.